(PRWEB) July 23, 2014
Last year, Formedix celebrated its partnership with OmniComm Systems, a leading global provider of data management solutions for clinical trials. The company launched its integration with TrialMaster, a leading-edge system for electronic data capture (EDC) and clinical data management. Formedix, a renowned provider of universal design and study execution tools added TrialMaster to its Transform for EDC product line. This latest, and much anticipated version of Transform for TrialMaster, is being released this week, in response to market demands for even tighter integration between these two prominent software products.
Formedix Transform can further enhance the fast study set-up times in TrialMaster by allowing instantaneous visualization of TrialMaster eCRFs as they are designed. In addition, study builds are automated, and drag-and-drop reuse is enhanced by leveraging portable, vendor neutral CDISC designs.
The new improved version of Transform for TrialMaster now includes the ability to specify edit checks, so that the vast majority of the TrialMaster study design may now be generated from the Formedix tool. In addition, new and exciting functionality enables a more streamlined TrialMaster to CDISC SDTM process by predicting TrialMaster dataset exports, prior to TrialMaster EDC build. Database programmers and biostatisticians can now produce specifications of how TrialMaster datasets will map to CDISC SDTM datasets before first patient in, thereby complementing TrialMaster’s ability to actually produce those SDTM datasets. Transform for TrialMaster, coupled with Formedix Origin, facilitates reuse of source TrialMaster dataset designs, target CDISC SDTM designs and mappings from study-to-study. All these new capabilities lead to even greater reductions in mapping reprogramming and QC activities and show reductions in the total time and cost of end-to-end trials.
This latest release from Formedix offers even more to CROs and sponsors, providing more choice when selecting an EDC system to build in. With Formedix, you can design in one tool and output to many EDC systems, meaning training only needs to happen in one tool.
Mark Wheeldon, CEO of Formedix discusses the relationship with OmniComm and explains the power of such partnerships. “By collaborating with OmniComm, not only can our customers take advantage of Formedix’s ability to reduce study specification times by over 60% but, with this new level of integration, all customers can benefit from automation from vendor neutral CDISC standards on an even greater scale.”
”For companies wishing to manage implementation-neutral global libraries, this new version of the Formedix Transform for TrialMaster provides a rich set of additional functionality,” said Keith Howells, Senior Vice President of Development for OmniComm Systems. “As adoption of TrialMaster EDC grows rapidly, we are delighted to see Formedix bringing these additional study design capabilities to market.”
Formedix clinical trial automation software and services enable you to remove manual, expensive, inefficient and labor intensive tasks from study set-up, EDC build, validation and submission publication processes. In fact, across every area of your end-to-end clinical trial, the time and cost savings they deliver speak for themselves and continue to do so time and time again. Formedix saves 68% in set-up time and 55% in EDC build time. With 70% reuse of your content, resources are cut by 23%. It’s all in the numbers.
About OmniComm Systems
OmniComm Systems is a leading strategic software solutions provider to the life sciences industry. OmniComm Systems is dedicated to helping the world’s pharmaceutical; biotechnology; contract research organizations; diagnostic and device firms; and academic medical centers maximize the value of their clinical research investments. Through the use of innovative and progressive technologies these organizations drive efficiency in clinical development, better manage their risks, ensure regulatory compliance and manage their clinical operations performance. OmniComm provides comprehensive solutions for clinical research with an extensive global experience from over 4,000 clinical trials. For more information, visit http://www.omnicomm.com.